3SBio files application for Phase I anemia trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Subject Terms:
    • Abstract:
      The article reports on the application submitted by 3SBio Inc., a Chinese biotechnology company, for a Phase I clinical trial for NuPIAO, a highly glycosylated erythropoiesis-stimulating agent with extended half-life and increased biologic activity to the Chinese State Food and Drug Administration.